Skip to content
IV Infusion Allopathic

Defalix 65 mcg/vial iv infusion

Generic: Difelikefalin Acetate

Company: Eskayef Pharmaceuticals Ltd.. Prices are as listed on BestinMeds; your pharmacy price may differ.

Strength65 mcg/vial
PackNot listed yet

Reviewed by: not listed yet. Source: not listed yet.

Last updated September 20, 2025.

Compare

Same generic, same strength

Sorted by price per iv infusion. Ask your pharmacist before you switch brands.

Difelikefalin Acetate 65 mcg/vial iv infusions

Prices as listed on BestinMeds.

No price is listed for this strength yet.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250
Medicine guide

About this medicine

What this medicine is for, how to take it, and what to watch for.

Read the full Difelikefalin Acetate guide

Indications

Difelikefalin Acetate IV Infusion is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD-aP) in adults undergoing hemodialysis.

Dosage and administration

Recommended dosage is 0.5 mcg/kg. Administer by intravenous bolus injection into the venous line of the dialysis circuit at the end of each hemodialysis treatment। Do not mix or dilute Difelikefalin Acetate prior to administration। Administer within 60 minutes of syringe preparation. If a regularly scheduled hemodialysis treatment is missed, resume Difelikefalin Acetate at the end of the next hemodialysis treatment. PEDIATRIC USE: The safety and effectiveness of Difelikefalin Acetate in pediatric patients have not been established. GERIATRIC USE: No overall differences in safety or effectiveness of Difelikefalin Acetate have been observed between patients 65 years of age and older and young adult subjects.

Side effects

The most common adverse reactions are diarrhea, dizziness, nausea, gait disturbances, including falls, hyperkalemia, headache, somnolence, and mental status change.

Precautions and warnings

Dizziness, Somnolence, Mental Status Changes, and Gait Disturbances: Dizziness, somnolence, mental status changes, and gait disturbances, including falls, have occurred in patients taking Difelikefalin Acetate and may subside over time with continued treatment. Concomitant use of centrally-acting depressant medications, sedating antihistamines and opioid analgesics may increase the likelihood of these adverse reactions and should be used with caution during treatment with Difelikefalin Acetate. Risk of Driving and Operating Machinery: Dizziness, somnolence, and mental status changes have occurred in patients taking Difelikefalin Acetate. Difelikefalin Acetate may impair the mental or physical abilities needed to perform potentially hazardous activities such as driving a car and operating machinery. Advise patients not to drive or operate dangerous machinery until the effect of Difelikefalin Acetate on a patient’s ability to drive or operate machinery is known.

Pregnancy and lactation

The limited human data on use of Difelikefalin Acetate in pregnant women are not sufficient to evaluate a drug-associated risk for major birth defects or miscarriage. There are no data regarding the presence of Difelikefalin Acetate in human milk or effects on the breastfed infant or on milk production.

Clinical details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250